Thirty-five hepatitis C virus-positive patients ( 17 with asymptomatic mixed cryoglobulinaemia , 5 with symptomatic mixed cryoglobulinaemia , and 11 without mixed cryoglobulinaemia ) were treated with triple boceprevir-based antiviral therapy .